BFSP2
Phakinin
Also known as: BFSP2_HUMAN, CP47, CP49, LIFL-L, phakinin
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13515
- Gene
- BFSP2
- Ensembl
- ENSG00000170819
- Chromosome
- 3
- Canonical length
- 415 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
More than 99% of the vertebrate ocular lens is comprised of terminally differentiated lens fiber cells. Two lens-specific intermediate filament-like proteins, the protein product of this gene (phakinin), and filensin, are expressed only after fiber cell differentiation has begun. Both proteins are found in a structurally unique cytoskeletal element that is referred to as the beaded filament (BF). Mutations in this gene have been associated with juvenile-onset, progressive cataracts and Dowling-Meara epidermolysis bullosa simplex. [provided by RefSeq, Jun 2009]
Canonical amino-acid sequenceUniProt
415 residues, UniProt reviewed canonical sequence.
>Q13515|BFSP2
1 MSERRVVVDL PTSASSSMPL QRRRASFRGP RSSSSLESPP ASRTNAMSGL VRAPGVYVGT
61 APSGCIGGLG ARVTRRALGI SSVFLQGLRS SGLATVPAPG LERDHGAVED LGGCLVEYMA
121 KVHALEQVSQ ELETQLRMHL ESKATRSGNW GALRASWASS CQQVGEAVLE NARLMLQTET
181 IQAGADDFKE RYENEQPFRK AAEEEINSLY KVIDEANLTK MDLESQIESL KEELGSLSRN
241 YEEDVKLLHK QLAGCELEQM DAPIGTGLDD ILETIRIQWE RDVEKNRVEA GALLQAKQQA
301 EVAHMSQTQE EKLAAALRVE LHNTSCQVQS LQAETESLRA LKRGLENTLH DAKHWHDMEL
361 QNLGAVVGRL EAELREIRAE AEQQQQERAH LLARKCQLQK DVASYHALLD REESGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BFSP2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 0.4 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 0.4 nTPM
- tonsil: 0.4 nTPM
- stomach: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- plasma cells: 149 nCPM
- epididymal principal cells: 26 nCPM
- b-cells: 21 nCPM
- t-cells: 21 nCPM
- parietal cells: 8.8 nCPM
- early spermatids: 6.6 nCPM
Immune cell
- T-reg: 13 nTPM
- memory CD4 T-cell: 1.6 nTPM
- eosinophil: 0.3 nTPM
- gdT-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
Brain region
- cerebral cortex: 0.4 nTPM
- white matter: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- hippocampal formation: 0.2 nTPM
- amygdala: 0.1 nTPM
- hypothalamus: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BFSP2.
Disease | AllUniProt
Conditions BFSP2 is implicated in, by any mechanism.
- Cataract 12, multiple types (CTRCT12) MIM:611597
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 161 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cataract 12 multiple types
- BFSP2-related disorder
- 7 conditions
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BFSP2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BFSP2 as an antibody target. Whether an autoantibody or antibody against BFSP2 could matter depends on whether native BFSP2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BFSP2 is annotated at the cell surface, where native BFSP2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BFSP2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...